Previous Article | Next Article 
Infection and Immunity, July 2000, p. 4225-4237, Vol. 68, No. 7
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Cryptococcus neoformans Is a Facultative
Intracellular Pathogen in Murine Pulmonary Infection
Marta
Feldmesser,1,*
Yvonne
Kress,2
Phyllis
Novikoff,2 and
Arturo
Casadevall1,3
Department of Medicine, Division of
Infectious Diseases,1 and Departments of
Pathology2 and Microbiology and
Immunology,3 Albert Einstein College of
Medicine, Bronx, New York 10461
Received 31 January 2000/Returned for modification 17 March
2000/Accepted 19 March 2000
 |
ABSTRACT |
To produce chronic infection, microbial pathogens must escape host
immune defenses. Infection with the human pathogenic fungus Cryptococcus neoformans is typically chronic. To understand
the mechanism by which C. neoformans survives in tissue
after the infection of immunocompetent hosts, we systematically studied the course of pulmonary infection in mice by electron microscopy. The
macrophage was the primary phagocytic cell at all times of infection,
but neutrophils also ingested yeast. Alveolar macrophages rapidly
internalized yeast cells after intratracheal infection, and
intracellular yeast cells were noted at all times of infection from
2 h through 28 days. However, the proportion of yeast cells in the
intracellular and extracellular spaces varied with the time of
infection. Early in infection, yeast cells were found predominantly in
the intracellular compartment. A shift toward extracellular
predominance occurred by 24 h that was accompanied by macrophage
cytotoxicity and disruption. Later in infection, intracellular
persistence in vivo was associated with replication, residence in a
membrane-bound phagosome, polysaccharide accumulation inside cells, and
cytotoxicity to macrophages, despite phagolysosomal fusion. Many
phagocytic vacuoles with intracellular yeast had discontinuous
membranes. Macrophage infection resulted in cells with a distinctive
appearance characterized by large numbers of vacuoles filled with
polysaccharide antigen. Similar results were observed in vitro using a
macrophage-like cell line. Our results show that C. neoformans is a facultative intracellular pathogen in vivo.
Furthermore, our observations suggest that C. neoformans occupies a unique niche among the intracellular pathogens whereby survival in phagocytic cells is accompanied by intracellular
polysaccharide production.
 |
INTRODUCTION |
Cryptococcus neoformans
is the causative agent of cryptococcosis, a life-threatening fungal
infection (reviewed in reference 45). C. neoformans infections can occur in individuals with both normal
and impaired immune function, but most cases are found in patients with
immune deficiency. C. neoformans infections are acquired
from the environment, presumably by inhalation of infectious particles
(17). In immune-competent hosts, most primary infections are
believed to be asymptomatic (41). Evidence that exposure to
C. neoformans is common comes from serological studies that demonstrate the presence of antibodies in the majority of normal individuals (7, 12). Many infections are believed to result from reactivation of latent infection (25). Hence, this
organism has adapted for persistence in tissue, but the mechanism by
which it resists immune clearance is not well understood
(5).
The traditional view of cryptococcal pathogenesis is that, as with
encapsulated bacteria, its polysaccharide capsule prevents phagocytosis
and that disease is caused by extracellular accumulations of organisms
and polysaccharide, resulting in host tissue compression (41,
58). When provided with complement or antibody opsonins, phagocytic cells are able to ingest C. neoformans in vitro.
In humans, phagocytosis of C. neoformans by monocytes is
followed by phagosomal acidification and phagolysosomal fusion
(40). However, phagocytosis is not always accompanied by
fungal killing, and there is convincing in vitro evidence that this
pathogen can replicate intracellularly (13, 14, 36, 38).
Although in vitro studies can provide important insights into the
mechanisms of microbial pathogenesis, it is essential to validate in
vitro observations in vivo before these are accepted as physiologically relevant. Today, C. neoformans is suspected of being capable
of intracellular pathogenesis in vivo, but this has never been
convincingly demonstrated. The demonstration that a pathogen can
replicate intracellularly in vivo is a difficult experimental task
because techniques for dynamic studies of infected tissues are not
available. For many microbes classically thought to be intracellular
pathogens, this property has been inferred but not rigorously proven.
The immunologic mechanisms of host defense against pulmonary C. neoformans infections have been extensively studied in
experimental animals (reviewed in reference 5). The
inflammatory response to primary cryptococcal infection in the lung has
been studied primarily by light microscopy. The literature contains
only limited ultrastructural information, most of which is derived from
in vitro systems (36, 51). In tissue, ultrastructural
studies of biopsies of human cutaneous cryptococcosis have described
budding yeast within macrophages (27) and vacuolation of
macrophage cytoplasm (48). Studies with experimental animals
have examined macrophage morphologic and cytoplasmic changes in
peritoneal exudates of guinea pigs, rats, and rabbits after
intraperitoneal infection with C. neoformans (34,
51) and in hepatic granulomas in rats after intravenous (i.v.)
infection (54). The ultrastructural appearance of
intravascular granulomas in the lungs in rats after i.v. inoculation
has also been described (63). These studies have each
provided important information about host cell-cryptococcus interactions. However, there has not been a systematic ultrastructural study of experimental pulmonary cryptococcosis over the course of infection.
We approached the question of whether C. neoformans is a
facultative intracellular pathogen by systematically studying pulmonary infection in mice by light microscopy and electron microscopy (EM). The
results showed that the capsule did not prevent phagocytosis in vivo
and that the yeast cells survived and replicated inside macrophages,
despite phagolysosomal fusion. Intracellular replication was associated
with cytotoxicity and profuse intracellular polysaccharide production.
The results demonstrated that pulmonary infection is a highly dynamic
process whereby the location of C. neoformans cells changes
during the course of infection as a function of intracellular
replication and the degree of inflammation.
 |
MATERIALS AND METHODS |
C. neoformans.
ATCC strain 24067 (serotype D) was used
for most experiments (21). This strain was selected because
it has been used in previous studies of pulmonary pathology
(18-20). One experiment was done with strain H99 (serotype
A), the type strain for C. neoformans var. grubii
(22). Another experiment was done with the acapsular strain
Cap 67 or its parent strain 3501 (serotype D) (23). Isolates
were maintained at
80°C. Cultures were started by inoculation of
Sabouraud dextrose broth (Difco, Detroit, Mich.) with a loopful of
frozen stock and incubated for 48 h at 30°C with moderate
shaking. Cells were washed three times in sterile phosphate-buffered
saline (PBS) and counted using a hemacytometer, and the count was
confirmed by plating on Sabouraud dextrose agar. For one experiment,
organisms were killed by heating to 55°C for 30 min. Plating of the
culture after heating demonstrated >99.9% killing.
Infection.
Specific-pathogen-free C57BL/6 mice, A/JCr mice,
and 129/SvEv mice were obtained from the National Cancer Institute
(Bethesda, Md.), Jackson Laboratories (Bar Harbor, Maine), or Taconic
Laboratories (Germantown, N.Y.). Within each experiment, mice were of
the same sex. Mice were 6 to 10 weeks old at the time of infection.
Mice were infected intratracheally as described earlier
(18). Briefly, mice were anesthetized with 65 mg of sodium
pentobarbital per kg and then inoculated intratracheally with
104 or 106 organisms in 0.05 ml of sterile PBS
via a midline neck incision, except where indicated. The higher
inoculum was used for experiments in which mice were studied prior to
24 h because it allowed organisms to be seen in sufficient numbers
by EM early after infection. In the following sets of experiments, mice
were infected concurrently and were killed by cervical dislocation at
the indicated times: (i) 2 h and 14 days (repeated twice); (ii)
24 h, 48 h, 7 days, and 28 days; (iii) 8, 16, and
24 h after infection with live yeast of strain 24067, 24 h
after infection with strains 3501 and Cap 67 and the heat-killed yeast
of strain 24067 (106 organisms for all), and 14 days after
infection with strains Cap 67 (108 yeast cells) and 3501 (104 yeast cells); and (iv) 2 h, 7 days, and 14 days
after infection with strain H99. To evaluate whether our findings in
C57BL/6 mice were present in other mouse strains, A/JCr mice and
129/SvEv mice infected with strain 24067 were studied on days 14 and 26 (A/JCr mice) or on days 13 and 28 (129/SvEv mice) after infection. In each experiment, two mice were studied for each group. Their lungs were
fixed in Trump's fixative (4% paraformaldehyde and 1% glutaraldehyde in 0.1 M phosphate buffer) for EM. One lobe of the lung was fixed in
10% buffered formalin and embedded in paraffin for light microscopic comparison. In three additional experiments, lungs of C57BL/6 mice
infected for 2 h and 14 days were processed for acid phosphatase cytochemistry as described below. In total, the study included analysis
of 249 blocks from 74 mice, 105 of which were studied by EM, and
includes data from three mouse strains and four cryptococcal strains,
representing two serotypes, three of which are encapsulated. At least
three 1-µm toluidine blue-stained sections of all blocks were
examined by light microscopy, and representative blocks were selected
for examination by EM.
Microscopy.
EM of lung tissue was performed according to a
published procedure (19). Immunogold histochemistry was
performed using either monoclonal antibody (MAb) 2H1 or MAb 18B7,
murine immunoglobulin G1 (IgG1) antibodies that bind to the
glucuronoxylomannan component of C. neoformans capsular
polysaccharide (CNPS) (4) as described earlier
(3). For primary MAb staining, grids were incubated overnight at 4°C in 5 µg of MAb 2H1 or murine IgG (Sigma) per ml as
a control. Acid phosphatase cytochemistry was performed on lung
sections using either cytidine monophosphate or sodium trimetaphosphate
(Sigma, St. Louis, Mo.), as previously described (15, 50).
Tissue from uninfected mice and infected tissue that was not incubated
in substrate served as controls. To demonstrate colocalization of acid
phosphatase activity and CNPS, sections incubated in trimetaphosphate
were subsequently stained with MAb 2H1, as described above, except that
phosphate-free buffers were used, the H2O2
incubation and etching were eliminated, and sections were imaged
without subsequent uranyl or lead staining.
The percentage of intact intracellular yeast was calculated at 7, 14, and 28 days after infection by counting ca. 50 to 100 intracellular
yeast cells on random micrographs obtained at each time point. Yeasts
were considered to be "intact" if their cytoplasm and intracellular
organelles were clearly visible and the shape of the cell wall was
regular. Phagosome and capsule diameters were measured, and the volumes
were calculated. For the calculation of phagosome volume, only
phagosomes containing one yeast cell were included.
Budding index.
The number of cryptococci with buds whose
cell wall was continuous with that of a parent yeast cell was divided
by the total number of yeast cells in an oil immersion field of a
1-µm section stained with toluidine blue and magnified ×1,000. Five
fields were counted for each mouse. Statistical analysis was performed using the two-tailed paired t test and was calculated using
Microsoft Excel 97 (Redmont, Wash.).
In vitro experiments.
Phagocytosis assays were performed
with the murine macrophage-like cell line J774.16. A total of
105 cells were plated per well on 96-well tissue culture
plates and were stimulated with gamma interferon (100 U/ml) and
lipopolysaccharide (0.2 µg/ml) for 28 h. Allowing for doubling
of cells and to achieve an effector/target ratio of 1:2, 4 × 105 yeast cells of strain Cap 67 or 3501 were then added to
the wells in medium containing 10% fresh normal mouse serum from
C57BL/6 mice. The plates were incubated at 37°C with 10%
CO2 for 3 h. The wells were washed three times with
fresh medium to remove extracellular yeast and mouse serum, preventing
further phagocytosis. At this time and after total incubation times of
18, 42, and 66 h, five wells for each strain were washed, fixed
with methanol, and stained with Giemsa. A fifth well was stained with
trypan blue to assess J774 cell viability; three to eight
determinations in which 50 to 100 cells were counted were made both for
total cell viability (all J774 counted) and for viability of J774 cells with intracellular yeast. In Giemsa-stained wells, the number of yeast
cells per J774 cell that contained intracellular yeast cells was
counted for >100 J774 cells per well. The percentage of phagocytic
cells was determined by counting the number of J774 cells with
intracellular yeast in 100 cells. Four fields were counted per well and
were averaged. For each time, assays were also performed in wells of
chamber slides (Nalge Nunc International, Naperville, Ill.), and
immunohistochemistry for CNPS was performed using MAb 2H1 as described
elsewhere (46). Statistical analysis was performed by Newman
Keuls test after analysis-of-variance determination (Primer of
biostatistics: the program, version 3.01; McGraw-Hill, Inc.).
 |
RESULTS |
Overview of pulmonary infection at the ultrastructural level.
The course of pulmonary infection with ATCC strain 24067 in C57BL/6 and
A/JCr mice has been described previously at the light microscopic level
by us and by others (18, 20, 31). Alveolar macrophages are
known to be the major phagocytic cell in the lung (20).
Preliminary experiments revealed that a substantial number of yeast
cells were located inside macrophages at 2 h after infection, but
by 24 h most yeast cells were extracellular. To gain insight into
this observation, we determined the proportion of intracellular yeast
at additional times in the first 24 h after infection (Fig. 1). The percentage of yeast cells found
inside phagocytic cells was maximal at 8 h and then declined until
24 h. Many macrophages containing C. neoformans had a
low electron density relative to the adjacent cells, a finding
consistent with cell damage (Fig. 2).
Neutrophils were often observed in close proximity to dead or dying
macrophages. The shift from intracellular predominance to extracellular
predominance coincided with the appearance of cellular debris in the
extracellular space in close proximity to yeast cells (data not shown),
which may have resulted from host cell or cryptococcal cell
destruction. Hence, the initial course of pulmonary infection in mice
involves rapid phagocytosis of C. neoformans cells,
macrophage toxicity, neutrophil influx, and cellular disruption.

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 1.
Location of C. neoformans. The percentage of
intracellular yeast for each group was determined by counting all yeast
cells on 4 or 5 noncontiguous grids for each of two mice (8 to 10 grids
per group). Heat-killed yeast of strain 24067 and live yeast of strain
3501 were studied 24 h after infection. Bars represent means;
error bars denote standard deviations. All pairwise comparisons between
tissues infected with strain 24067 were statistically significantly
different as determined by Student's t test with the
Bonferroni correction except for comparison between the tissues
obtained at 2 and 16 h and between the tissue obtained at 8 h
and tissue from mice infected with heat-killed yeast.
|
|

View larger version (184K):
[in this window]
[in a new window]
|
FIG. 2.
Intracellular replication and cytopathic effects of
C. neoformans. (A and B) Phagosomes containing multiple
yeast cells, demonstrating heterogeneity of size within the phagosome
and budding forms. Bars, 10 µm. Time after infection: A, 28 days; B,
7 days. (C) Macrophage containing several intracellular C. neoformans cells at 7 days shows cytoplasmic disruption. The arrow
points to membrane-bound cellular debris seen in proximity to this
cell, suggesting that cellular destruction is a consequence of
infection. (D) Multinucleated giant cell at 28 days demonstrating
numerous intracellular yeast cells and abundant cytoplasmic
vacuolation. Bars, 1 µm.
|
|
At 48 h and 7 days after infection, C. neoformans cells
were found in both intracellular and extracellular spaces. Beginning 7 days after infection, there was a shift toward intracellular predominance that coincided with the appearance of multinucleated cells
and granulomatous inflammation. Nevertheless, there was considerable
inter- and intraexperimental variation, such that in some tissue blocks
there was extracellular predominance, whereas in others most yeast
cells were inside phagocytic cells. Granulomatous inflammation, as
defined by the presence of organized collections of macrophages
(1), was present in lung tissue at 14 and 28 days. By 28 days, the location of C. neoformans was predominantly intracellular, and most yeast cells were found inside multinucleated giant cells. No yeast cells were observed inside blood vessels.
Neutrophil infiltration.
At 2 and 8 h after infection,
occasional neutrophils were present adjacent to extracellular
cryptococci (Fig. 3). Neutrophils were
observed only in infected areas of the lung and were the only
inflammatory cells noted in contact with yeast apart from macrophages.
By 16 h after infection, clusters of one to three neutrophils were
present near extracellular yeast cells and adjacent to macrophages
containing intracellular yeast. At 48 h after infection, occasional collections of neutrophils consisting of one to four cells
abutted extracellular yeast. Neutrophils were present through day 7, after which time they were rarely seen. On day 7 after infection,
collections of inflammatory cells were more prominent, and larger
groups of neutrophils were seen, some of which contained intracellular
yeast. Others surrounded dead macrophages with intracellular yeast.
Cryptococcal CNPS was only detected by immunoelectron microscopy in
phagosomes that contained yeast, suggesting that neutrophils did not
phagocytose shed polysaccharide (data not shown).

View larger version (90K):
[in this window]
[in a new window]
|
FIG. 3.
Neutrophils in close contact with C. neoformans in tissue. (A) A collection of neutrophils abuts an
extracellular yeast in the alveolar space 48 h after infection. (B
and C) At 7 days after infection, neutrophil phagocytosis of C. neoformans is seen, suggesting a role for neutrophils in host
defense in vivo. Bars, 1 µm.
|
|
Phagolysosomal fusion.
Phagolysosomal fusion was observed in
alveolar macrophages 2 h after infection (Fig.
4). In addition, acid
phosphatase-positive vesicles and tubular structures were in close
proximity to phagosomes containing yeast cells, and acid phosphatase
activity at the periphery of some phagosomes demonstrated
phagolysosomal fusion. At 14 days, acid phosphatase reaction product
lined the inside of many phagosomes. In phagosomes that contained acid
phosphatase activity, most staining was present at the outer surface of
the capsule. In uninfected macrophages, acid phosphatase reaction
product was limited to well-demarcated lysosomal structures. No
reaction product was seen in infected control tissue incubated without
substrate. Consistent with prior studies, acid phosphatase-positive
vacuoles were present inside C. neoformans (33,
43), but no activity was present in the capsule of extracellular
yeast or at the phagosome periphery when lysosomes were not in contact
with phagosomes. These findings suggest that the acid phosphatase
lining the phagosomes originated from macrophages.

View larger version (158K):
[in this window]
[in a new window]
|
FIG. 4.
Phagolysosomal fusion. (A) Intracellular cryptococcus
2 h after infection. Macrophage lysosomes have moved toward the
yeast and appear to fuse with the phagosome. Asterisk denotes
artifactual contraction of the cryptococcal capsule from the wall of
the phagosome. (B and C) Higher magnification of areas contained within
rectangles in panel A demonstrates the fusion of lysosomes with the
phagosome. Electron-dense material at the periphery of the phagosome
likely represents entry of lysosomal components into phagosome. (D and
E) Acid phosphatase cytochemistry 2 h after infection
demonstrating lysosomal fusion with the phagosome, with entry of the
black reaction product into the phagosome. Panel E is a
higher-magnification view of the rectangular region shown in panel D. (F to H) Vacuoles containing black deposits representing acid
phosphatase activity (arrows) are fused with phagosomes containing
C. neoformans on day 14. Many small cytoplasmic vacuoles
without yeast have acid phosphatase activity, suggesting that they are
lysosomes. Some of these vacuoles are in direct continuity with the
phagosome (E), while others are discontinuous. (F) Acid phosphatase
reaction product is also visible at the periphery of the phagosome.
Bars, 1 µm.
|
|
Intracellular replication.
Examination of lung tissue sections
provided strong evidence for intracellular replication of C. neoformans in macrophages. During the first 24 h, most
phagosomes contained one organism, but after this time both the number
of yeast cells per phagosome and the number of phagosomes per
macrophage or multinucleated giant cell increased (Fig. 2; Table
1). The sizes of yeast cells within
single phagosomes became increasingly heterogeneous, a finding
consistent with ongoing budding. Yeast cells at a variety of stages in
the budding process were observed intracellularly (data not shown).
Analysis of lung sections from mice on day 14 with sizable collections
of both intracellular and extracellular yeast showed that the mean
budding index was higher for intracellular than for adjacent
extracellular yeast (6.8 ± 5.3 versus 1.3 ± 1.4;
P = 0.005 by paired Student t test).
Although limited ultrastructural study of C. neoformans
budding in vitro suggests that the capsule is thin at the leading edge
of the bud (6, 35), budding extracellular yeast cells in the
lung were contained within large masses of CNPS (Fig.
5). We also noted that, consistent with
intracellular survival, the percentage of intact yeast cells in
macrophages was 60 to 76% at 7, 14, and 28 days of infection.

View larger version (189K):
[in this window]
[in a new window]
|
FIG. 5.
Geometry of extracellular budding. Extracellular
organisms at various stages of budding. Photos were obtained in
129/SvEv mice 13 days after infection. Bars, 1 µm. Arrows point to
buds. At all stages, the buds are encased in structures that label with
MAb to CNPS. This phenomenon was seen in all three mouse strains and
with all three encapsulated cryptococcal strains in C57BL/6 mice.
|
|
Effects of C. neoformans on macrophages.
C.
neoformans intracellular residence was associated with
cytotoxicity to host phagocytic cells. At 2 h after infection
macrophages with intracellular yeast appeared intact, but by 8 h
after infection the cell membrane of some macrophages with
intracellular yeast was disrupted, a result consistent with cell
destruction as a consequence of phagocytosis of yeast. By 16 h
after infection many macrophages had cytoplasmic areas with few
organelles and lower electron density in regions of contact with
extracellular and intracellular cryptococci (blebs) (Fig.
6).

View larger version (72K):
[in this window]
[in a new window]
|
FIG. 6.
Cytoplasmic blebs in macrophages with internalized
C. neoformans. Adjacent to phagosomes containing yeast, the
macrophage cytoplasm developed hypolucent areas (blebs) with few
organelles (arrows) at regions of contact with extracellular
cryptococci. These may represent a precursor for the increasing
cytoplasmic disruption seen with increasing time after infection. Bars,
1 µm. Times after infection: A, 48 h; B, 8 h; C, 24 h.
|
|
After 48 h, there was a gradual and progressive increase in the
number of cytoplasmic vacuoles in phagocytic cells containing yeast.
Some membrane-bound vacuoles contained lamellar-body-like structures
that are seen in lysosomes, and others contained amorphous material. At
7 days vacuolation of the macrophage cytoplasm was more prominent, and
by 14 and 28 days extensive vacuolation resulted in cytoplasmic
disruption (Fig. 2). By light microscopy, the vesicles appear in
toluidine blue-stained sections as holes in the macrophage cytoplasm
(data not shown). Ultrastructural characteristics of cell death
accompanied these findings, including rounding of macrophage nuclei and
cytoplasmic disruption. Staining with MAb to CNPS was used to determine
the vacuole contents and the intracellular location of cryptococcal
CNPS (Fig. 7). No gold was present in
sections incubated in normal mouse IgG or sections of uninfected lung
incubated in MAb 2H1, indicating that staining was specific. Many gold
particles were located inside vesicular structures that were 12 to 15 nm in diameter. By 48 h, gold was localized predominantly in
intracytoplasmic vacuoles or in the small vesicular structures.
Continuity between the CNPS-containing vacuoles and the phagosomes was
apparent (Fig. 8). Many of these vacuoles
also contained acid phosphatase activity, suggesting that they
originated from lysosomes. The cytoplasmic disruption seen in
association with progressive vacuolation and the presence of CNPS
inside these vacuoles indicate a cytotoxic pathologic process. However,
in areas of the lung in which large numbers of macrophages were
present, cells appeared to be of two types
those that contained large
numbers of yeast cells with the cytopathic changes described above and
those that contained single yeast cells but were otherwise
comparatively intact (data not shown). These findings were observed in
all of the conditions studied.

View larger version (129K):
[in this window]
[in a new window]
|
FIG. 7.
Immunoelectron microscopy for CNPS. (A) Two hours after
infection, lysosomes fuse with the phagosome containing C. neoformans. (B and C) Higher magnification of the areas within
rectangles seen in panel A. Gold particles inside lysosomes indicate
that the CNPS has entered the lysosome (arrows). (D and E)
Colocalization of gold particles demonstrating the presence of CNPS,
with acid phosphatase activity in cytoplasmic vacuoles 14 days after
infection. Note the continuity between spaces containing CNPS and
lysosomes. Sections were not counterstained with uranyl or lead. CN,
C. neoformans; Asterisks indicate cryptococcal capsules.
Arrows point to representative substrate deposition indicative of
lysosomal acid phosphatase activity. Arrowhead denotes acid phosphatase
activity inside C. neoformans. Bars, 1 µm.
|
|

View larger version (100K):
[in this window]
[in a new window]
|
FIG. 8.
Vacuole formation. (A and B) Pulmonary macrophages from
two C57BL/6 mice infected for 14 days demonstrating the network of
cytoplasmic vacuoles. Direct continuity is seen between the contents of
cytoplasmic vacuoles and phagosomes (arrows). Bars, 1 µm.
|
|
Phagosome volume and membrane.
Phagosome volume in vivo and in
vitro was a function of capsule volume for internalized C. neoformans cells (data not shown). The average phagosome volume
increased with the time of infection, reflecting an increase in the
average capsule size of C. neoformans cells in the lung.
Several giant phagosomes having volumes of >10,000 µm3
were observed. Phagosome size increased incrementally with the time of
infection from day 7 onward such that at days 7, 14, and 28 the volume
of phagosomes containing single yeast cells were 98 ± 134 (n = 17 phagosomes), 254 ± 263 (n = 22), and 2,296 ± 2,383 (n = 10)
µm3, respectively (P < 0.001;
Kruskal-Wallis test). Analysis of several hundred phagosomes containing
cryptococci revealed that in many cells the phagocytic membrane was
discontinuous, even when nearby nuclear, plasma, and endoplasmic
reticulum membranes appeared intact (Fig.
9). Macrophages with discontinuous
phagosomal membranes were observed at all times of infection.

View larger version (217K):
[in this window]
[in a new window]
|
FIG. 9.
Phagosomal membrane disruption. Macrophage phagosomes
containing C. neoformans in a C57BL/6 mouse 48 h after
infection (A and B) and in an A/JCr mouse 14 days after infection (C
and D) demonstrate areas in which the phagosome membrane is
discontinuous (arrows), despite the appearance of well-defined
membranes in cytoplasmic organelles. Panels B and D are enlargements of
areas contained in the rectangles in panels A and C, respectively. The
asterisk in panel C demonstrates well-preserved membranes in the Golgi
apparatus. The arrowheads in panels C and D demonstrate sharply defined
phagosomal membrane coexisting in a cell in which a phagosomal membrane
is disrupted. Bars, 1 µm.
|
|
Fate of live versus dead C. neoformans.
The observation
that at 24 h the majority of yeast cells were in the extracellular
space suggested profuse extracellular replication, intracellular
replication with lysis, or both. To investigate these possibilities, we
compared the locations of live and heat-killed yeast cells instilled
into mouse lungs. When heat-killed yeast cells were used, examination
of lung tissue 24 h later revealed that all yeast cells were
intracellular. However, cytopathic changes were seen inside cells
containing heat-killed yeast, and neutrophils were prominent in the
inflammatory infiltrate surrounding these macrophages (data not shown).
CNPS in intracellular pathogenesis.
To investigate the
requirement for capsule production for C. neoformans
intracellular pathogenesis, we compared the outcome of pulmonary
infection with the acapsular strain Cap 67 and its encapsulated
parental strain 3501 (23). When the acapsular strain was
instilled into the lungs, almost all yeast cells were found intracellularly in macrophages and neutrophils at 24 h after
infection (data not shown). Macrophages contained one or two phagosomes per cell, with one yeast cell per phagosome. The macrophage cytoplasm and nuclei appeared normal. All yeast cells were approximately the same
size, and no budding forms were found. At 14 days after infection, the
lungs of mice infected with the acapsular strain were normal and no
organisms were seen, a finding consistent with the clearance of
pulmonary infection. In contrast, the appearance of lung tissue
infected with strain 3501 for 24 h or 14 days was similar to that
seen with strain 24067. Many macrophages contained multiple phagosomes
with more than one yeast cell, and the macrophage cytoplasm contained
vacuoles similar to those seen with strain 24067. In addition to
intracellular polysaccharide synthesis, the polysaccharide capsule may
contribute to intracellular survival by providing a buffer space
between the site of lysosome-phagosome fusion and the fungal cell wall
(Fig. 10). At 24 h after
infection, the distance between the phagosome membrane and cell wall
for phagocytosed encapsulated cells was 8.6 times that for the
nonencapsulated strain (0.11 ± 0.03 µm [n = 8
cells] and 0.95 ± 0.05 µm [n = 12 cells;
P <0.001 by Student's t test], for strains Cap
67 and 3501, respectively).

View larger version (112K):
[in this window]
[in a new window]
|
FIG. 10.
The distance between the phagosome membrane and the
C. neoformans cell wall is dependent on the size of the
capsule. (A) Phagosome containing a nonencapsulated Cap 67 mutant has
the phagosomal membrane in close apposition to the fungal cell wall.
(B) In a phagosome containing the encapsulated strain 3501, the
polysaccharide capsule is interposed between the phagosomal membrane
and the cell wall. Bars, 1 µm.
|
|
Studies with A/JCr and 129/SvEv mice and C. neoformans
H99.
To establish whether the observations made were dependent on
the mouse strain, experiments were performed with two additional murine
strains. In both of these strains, intracellular budding yeast and
extensive cytoplasmic vacuolation were observed at 14 and 28 days after
infection. Variability occurred in the proportion of intracellular
yeast and in the size of extracellular yeast. For A/JCr mice,
intracellular replication and macrophage cytotoxicity were extensive,
while in 129/SvEv mice, phagosomes containing multiple yeast cells were
less commonly seen than in C57BL/6 mice. Hence, the phenomena of
intracellular replication and macrophage cytotoxicity seen in C57BL/6
mice are found in other mouse strains, but there may be variability
among macrophages from different mouse strains to control intracellular infection.
To establish whether the observations made with the serotype D strains
24067 and 3501 were restricted to this serotype, we conducted limited
studies with the serotype A strain H99. At 2 h after infection,
the majority of H99 cells in the alveolar space were ingested by
macrophages (data not shown), a result paralleling what was found early
during infection with strain 24067. At 14 days, cells of strain H99
were found inside macrophages, most of which showed signs of
cytotoxicity, as represented by extensive vacuolar formation, lower
electron density and, in some cases, disruption of plasma membranes.
Hence, the results with all three strains representing both serotypes
were qualitatively similar.
In vitro study.
In vitro interactions of C. neoformans and macrophages were studied using J774
cells and complement-derived opsonins. Complement was used as an
opsonin because C3 deposition has been demonstrated in the
C. neoformans capsule in the alveolar space
(18). In vitro experimentation confirmed that encapsulated,
but not acapsular, yeast cells replicated intracellularly and were
toxic to phagocytic cells. With increased incubation times, the number
of yeast cells per phagocytic J774 cell increased for the encapsulated,
but not the acapsular strain (Fig. 11).
Furthermore, higher percentages of J774 cells with intracellular
encapsulated yeast were dead or dying, but this was not the case with
acapsular yeast cells. J774 cells with intracellular encapsulated yeast
cells but not with intracellular acapsular yeast cells accounted for a
disproportionately high percentage of dead J774 cells at 42 and 66 h (data not shown). Immunohistochemistry confirmed the presence of
cytoplasmic CNPS, intracellular replication, and massively distended
phagosomes in J774 cells with intracellular encapsulated yeast (Fig.
11).

View larger version (47K):
[in this window]
[in a new window]
|
FIG. 11.
In vitro phagocytosis assay with J774 cells and
C. neoformans strains 3501 (encapsulated, black bars) and
Cap 67 (acapsular, white bars). Values represent means; error bars
denote standard deviations. (A) Percentage of J774 cells with number of
yeast cells (n = 1, 2, 3, 4, or >4) per J774 cell
after various times (t) of incubation. Statistical analysis compared
the percentage of J774 cells with >4 yeast cells per cell. Asterisks
denote P values of <0.05 compared to values at 3 h.
(B) Percentage of J774 cells with intracellular C. neoformans after various times of incubation. An asterisk denotes
a P value of <0.05 compared to the value at 3 h of
incubation with strain 3501. A double asterisk denotes a P
value of <0.05 compared to the value at 3 h of incubation with
strain Cap 67. (C) Percentage of dead J774 cells that contained
intracellular C. neoformans. An asterisk denotes a
P value of <0.05 compared to the value at 18 h of
incubation with strain 3501. The percentage of dead cells may be
underestimated because dead cells become unattached and are washed off
during the staining process. The loss of dead cells likely explains the
decrease in the percentage of J774 cells with intracellular yeast at
66 h of incubation with strain 3501 seen in panel B. (D)
Immunohistochemistry for CNPS using MAb 2H1. Top left, single cell of
strain 3501 inside an intact J774 cell after 3 h of incubation;
top right, J774 cell after 18 h of incubation with collections of
CNPS and single intracellular yeast demonstrating that, in some cases,
yeast cells appeared to be destroyed; bottom, J774 cells after 66 h of incubation with strain 3501 show cells with large vacuoles
containing multiple cryptococci with budding forms (left) and cells
with multiple phagosomes containing yeast cells heterogeneous in size,
consistent with active replication (right). All panels were
photographed at a magnification of ×1,000.
|
|
 |
DISCUSSION |
A long-held view in the field of C. neoformans
pathogenesis is that the capsule promotes virulence by being
antiphagocytic. This concept is based largely on the observation that
phagocytic cells rarely ingest encapsulated cells without opsonins in
vitro and on pathological studies that frequently show extracellular yeast cells in tissue. In the present study, we investigated the location of yeast cells at various times of infection by EM, which allows accurate localization of yeast to intra- and extracellular compartments through visualization of cellular landmarks. Practically all acapsular yeast cells were inside macrophages, but a small proportion of encapsulated cells were extracellular at all of the times
of infection examined. This observation supports a role for the capsule
in inhibiting phagocytosis in vivo. However, the more significant
result appears to be that the capsule does not prevent phagocytosis in
vivo. Phagocytosis in vivo may be explained by the fact that the lung
contains opsonins for C. neoformans, such as complement and
collectins (18, 55). The view that the polysaccharide
capsule of encapsulated bacteria is not antiphagocytic in vivo was
proposed almost 50 years ago (reviewed in reference 62) but is not widely accepted.
The location of C. neoformans cells in the lung is a
function of the time of infection. Shortly after intratracheal
infection, C. neoformans cells are found primarily inside
alveolar macrophages. By 24 h, the majority of C. neoformans cells were in the extracellular space. The higher
percentage of yeast cells found in the extracellular space at 24 h
relative to that found at 2 h is consistent with intracellular
replication followed by phagocytic cell lysis and release of live yeast
into the extracellular space. The possibility of intracellular growth
followed by cell lysis is supported by the present observation of cell
debris in close proximity to yeast cells and also to reports that
C. neoformans can replicate and lyse macrophage lineage
cells in vitro (14, 36). In mice given heat-killed C. neoformans, the majority of yeast cells at 24 h were inside
macrophages, demonstrating that limited clearance of dead yeast cells
occurs by this time. Consequently, clearance of intracellular yeast is
an unlikely explanation for our finding. The alternative explanation of
extracellular predominance resulting from more rapid replication of
C. neoformans in the extracellular space cannot be excluded,
but in vitro data has shown that growth inside macrophages is more
rapid than it is extracellularly (14).
The initial transition from intracellular predominance to extracellular
predominance was associated with macrophage cytotoxicity and
disruption, as indicated by (i) low cytoplasmic electron density and
membrane disruption and (ii) the appearance of cell debris in the
alveolar space in close proximity to extracellular yeast cells.
Although EM cannot directly determine cell viability, the findings of
reduced cytoplasmic electron density, rounding of nuclei, and disrupted
cellular membranes are accepted EM criteria for cell damage and death.
The fungal cell components responsible for macrophage cytotoxicity were
not characterized. These cytotoxic changes observed early in the course
of infection were unlike those described for later in infection. A
second form of cellular alteration consisted of the formation of
cytoplasmic blebs. Cytoplasmic blebs protruded into phagosomes and were
apparent in macrophage luminal surfaces in close proximity to
extracellular yeast cells. In 1993, Sakaguchi reported disorganization
of actin filaments in cytoplasmic areas in contact with C. neoformans in hepatic granulomas (54). A similar
phenomenon may be responsible for the cytoplasmic blebs observed in
alveolar macrophages in this study. The occurrence of cytoplasmic blebs
suggests that phagocytic cell contact with the C. neoformans
capsule results in alteration of the cell cytoskeleton.
Mice developed granulomatous inflammation, a finding consistent with
prior literature, which is indicative of a cell-mediated immune
response (28, 47). However, in several murine pulmonary infection models, cellular immunity is insufficient to control infection in the lung, and mice die with large pulmonary fungal burdens
(18, 20, 32). At later stages of infection (7 to 28 days),
progression of the inflammatory response toward granulomatous inflammation was accompanied by a shift toward a preponderance of yeast
cells being inside phagocytic cells. Phagocytosis of microorganisms can
lead to killing of the microbe or to microbial replication inside
phagocytic cells. Demonstrating that a pathogen replicates inside host
cells in vivo remains a formidable undertaking because the technology
does not exist for serial observations of undisturbed infected tissue
in vivo. For C. neoformans, in vitro studies provide
evidence for both intracellular killing and intracellular survival
followed by replication (26, 36, 37, 61). Furthermore,
pathological studies have been equivocal regarding the outcome of
phagocytosis in vivo, since intracellular localization has been
associated with both control and persistence of infection
(57). Our results demonstrated that intracellular residence
was associated with multiple yeast cells per phagosome, a higher
budding index, and the emergence of a yeast cell population that was
heterogeneous in size. We interpret these findings to be indicative of
intracellular replication in vivo. Preferential phagocytosis of budding
forms is an unlikely explanation for the measured higher budding index
inside cells since there was a relative paucity of budding cells in the
extracellular space and the extracellular buds were well encapsulated.
The most straightforward explanation of the data is that C. neoformans replicates inside macrophages in vivo, thus validating
similar observations previously made in vitro (14, 36, 38).
Intracellular residence is believed to confer significant advantages to
microbes by insulating them from immune effector mechanisms and
providing access to the nutrient-rich cellular interior but requires
evasion of microbicidal mechanisms of phagocytic cells. Other
facultative intracellular pathogens have specialized strategies for
intracellular survival, such as prevention of phagolysosomal fusion
(29), blockage of phagosomal acidification (2,
16), and escape from the phagosomal vacuole (24). For
C. neoformans, these strategies are not applicable, since
yeast cells are always in phagosomes, lysosomes fuse with the
phagosome, and phagosomal acidification occurs normally in vitro
(40). For C. neoformans, growth is enhanced at
the acidic pH of the lysosome relative to the neutral pH of serum
(39), and this may provide a growth advantage relative to
yeast cells in the extracellular space. Survival of C. neoformans in the phagolysosome may be aided by two unique
characteristics of this fungal pathogen: melanin synthesis and the
polysaccharide capsule. Melanin synthesis has been demonstrated in
yeast cells in lung tissue (49) and could potentially
protect the fungal cell against oxidative burst products and
microbicidal proteins in vitro (49, 60). The capsule
separates the phagolysosomal membrane from the yeast cell wall, and
this separation could limit the fungicidal effects of lysosomal
products. Furthermore, the average phagosomal volume increased with
time of infection because of increased capsule size. Large-volume
phagosomes may promote intracellular survival by causing a greater
dilution of antimicrobial substances released after lysosomal fusion.
This study demonstrates for the first time that macrophages ingesting
C. neoformans in vivo are filled with vesicles containing capsular polysaccharide. The result is a very distinctive appearance for macrophages that, to our knowledge, has no counterpart in any other
pathologic process. We have named these macrophages hueco cells
("hueco" means "hole" in Spanish). Inspection of micrographs from earlier studies suggests that cells resembling hueco cells also
occur in human C. neoformans infection (27, 30,
48). The polysaccharide inside the vesicles may originate from
phagocytosis of soluble extracellular polysaccharide or from
intracellular polysaccharide production by ingested yeast. Our analysis
of micrograph images strongly suggests that at least some of these
vesicles arise from intracellular polysaccharide production. Direct
connections were observed repeatedly between phagolysosomes containing
C. neoformans and polysaccharide-containing vesicles,
suggesting origin in association with the phagolysosome. Further, the
size of individual vesicles was relatively homogeneous, suggesting that
they arise from defined structures rather than from phagocytic events.
We propose that the vesicles originate from lysosomes and develop
following exchange of lysosomal contents with phagosomal polysaccharide
after phagolysosomal fusion. Regardless of the mechanism by which
vesicles arise, intracellular persistence of C. neoformans
in vivo was accompanied by the accumulation of polysaccharide antigen
in the cytoplasm of macrophages. This observation strongly suggests a
role for capsular polysaccharide in intracellular pathogenesis.
Our study also yielded the first evidence that C. neoformans
is cytotoxic to phagocytic cells in vivo. Host cell cytotoxicity is not
generally considered to be a characteristic of C. neoformans pathogenesis. Although EM cannot directly indicate the vitality of a
cell, inspection of macrophages containing yeast cells revealed that
such cells had reduced cytoplasmic electron density and disruption. These findings are accepted EM correlates of cytotoxicity and cell
death. In addition, we noted discontinuous phagosomal membranes in
several vacuoles containing C. neoformans in cells with
apparently intact nuclear and endoplasmic reticular membranes. Although
we cannot exclude the possibility that the discontinuities in the vacuolar membrane resulted from fixation and processing, the
simultaneous presence of intact membranes around other organelles in
those cells argues against an artifactual effect. Furthermore, C. neoformans produces several enzymes that are potentially toxic to
macrophages, including phospholipases and proteases (8, 9).
We found neutrophil phagocytosis of strain 24067 in C57BL/6 mice 7 days
after infection, but not at earlier or later times, despite intimate
association between these cells and yeast. The reason that the timing
of ingestion appears to be limited is unclear, but one possibility is
that neutrophils require a narrowly defined effector/target ratio, as
they do in vitro (11). The function of neutrophils in the
host response to cryptococcal infection is unclear. A role for
neutrophils as antifungal effector cells has been suggested by in vitro
and ex vivo studies (34, 56). In vitro, yeast cells must be
ingested to be killed by neutrophils (13, 44, 53, 59). Here
we report the first demonstration of phagocytosis of C. neoformans by neutrophils in vivo, supporting the possibility that
neutrophils contribute to cryptococcal killing. Data from human control
nervous system autopsy series suggests that neutrophils may be
recruited in response to tissue damage resulting from infection rather
than in response to the yeast itself (42). Our finding that
neutrophils were commonly associated with damaged macrophages
containing intracellular heat-killed yeast may represent such
neutrophil recruitment to damaged tissue. CNPS stimulates human
neutrophils to produce proinflammatory cytokines (52),
suggesting a potential immunomodulatory role.
Several studies have shown that C. neoformans can replicate
inside human monocytes and microglia in vitro, but comparable studies
have not been done with murine-derived cells. To investigate whether
the process observed in mice could be simulated in vitro, we infected
J774 cells with encapsulated and acapsular C. neoformans and
monitored the course of infection over 48 h. This cell line displays many macrophage properties and kills C. neoformans
when provided with antibody opsonins. In our experiment, we used
complement as the opsonin because C3 is available in the alveolar
space, whereas antibody responses are seldom made during murine
infection (18). Acapsular cells did not replicate
intracellularly and were not cytotoxic for J774 cells. In contrast,
encapsulated cells replicated intracellularly and killed the phagocytic
cell. These results support the proposal that the capsule is important
for intracellular survival and replication and that C. neoformans cells can be cytotoxic to phagocytic cells.
In summary, our results indicate that C. neoformans can
replicate inside phagocytic cells in vivo, thus establishing this fungus as a facultative intracellular pathogen in vivo. We propose that
C. neoformans intracellular replication and phagocytic cell destruction are major components of the pathogenic process for cryptococcal infection in the lung. Persistence of infection in lung
tissue may involve repeating cycles of phagocytosis, intracellular residence, and phagocytic cell destruction. Fungal replication in
murine C. neoformans pulmonary infection appears to occur
both intra- and extracellularly. Intracellular replication in vivo was
associated with the accumulation of macrophage cytoplasmic vesicles
that were filled with capsular polysaccharide and phagocytic cytotoxicity. The C. neoformans capsule appears to have a
very complex role in pathogenesis, functioning both offensively and defensively. These observations, together with prior studies, imply
that C. neoformans occupies a special niche among
intracellular pathogens, since the combined association of
intracellular polysaccharide production, melanin synthesis, phagocytic
cell vacuolation, and cytotoxicity represents a unique strategy for
intracellular persistence. These results are exciting because they
suggest many new directions for the study of C. neoformans pathogenesis.
 |
ACKNOWLEDGMENTS |
M.F. is supported by NIH grant AI01341. P.N. is supported by NIH
grant CA06576. A.C. is supported by NIH grants AI22774, AI13342, and
HL59842. A. Casadevall is a recipient of a Burroughs-Wellcome Fund
Scholar Award in Experimental Therapeutics.
We thank Jorge Bermudez for assistance with histopathology, Clemen
Cayetano and Valentin Storovoytov for assistance with electron microscopy, and the Graphic Arts Center of the Albert Einstein College
of Medicine. We also thank Gregory Serdahl, without whose assistance
this work could not have been completed.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Albert Einstein
College of Medicine, Golding Building, Rm. 701, 1300 Morris Park Ave., Bronx, NY 10461. Phone: (718) 430-4259. Fax: (718) 430-8701. E-mail: feldmess{at}aecom.yu.edu.
Editor:
T. R. Kozel
 |
REFERENCES |
| 1.
|
Adams, D. O.
1976.
The granulomatous inflammatory response.
Am. J. Pathol.
84:164-191[Medline].
|
| 2.
|
Antoine, J.-C.,
E. Prina,
C. Jouanne, and P. Bongrand.
1990.
Parasitophorous vacuoles of Leishmania amazonensis-infected macrophages maintain an acidic pH.
Infect. Immun.
58:779-787[Abstract/Free Full Text].
|
| 3.
|
Casadevall, A.,
W. Cleare,
M. Feldmesser,
A. Glatman-Freedman,
D. L. Goldman,
T. R. Kozel,
N. Lendvai,
J. Mukherjee,
L.-A. Pirofski,
J. Rivera,
A. L. Rosas,
M. D. Scharff,
P. Valadon,
K. Westin, and Z. Zhong.
1998.
Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies.
Antimicrob. Agents Chemother.
42:1437-1446[Abstract/Free Full Text].
|
| 4.
|
Casadevall, A.,
J. Mukherjee,
S. J. N. Devi,
R. Schneerson,
J. B. Robbins, and M. D. Scharff.
1992.
Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection.
J. Infect. Dis.
165:1086-1093[Medline].
|
| 5.
|
Casadevall, A., and J. R. Perfect.
1998.
Cryptococcus neoformans.
American Society for Microbiology, Washington, D.C.
|
| 6.
|
Cassone, A.,
N. Simonetti, and V. Strippoli.
1974.
Wall structure and bud formation in Cryptococcus neoformans.
Arch. Microbiol.
95:205-212[CrossRef].
|
| 7.
|
Chen, L. C.,
D. L. Goldman,
T. L. Doering,
L. Pirofski, and A. Casadevall.
1999.
Antibody response to Cryptococcus neoformans proteins in rodents and humans.
Infect. Immun.
67:2218-2224[Abstract/Free Full Text].
|
| 8.
|
Chen, L.-C.,
E. S. Blank, and A. Casadevall.
1996.
Extracellular proteinase activity of Cryptococcus neoformans.
Clin. Diagn. Lab. Immunol.
3:570-574[Abstract].
|
| 9.
|
Chen, S. C. A.,
M. Muller,
J. Z. Zhou,
L. C. Wright, and T. C. Sorrell.
1997.
Phospholipase activity in Cryptococcus neoformans: a new virulence factor?
J. Infect. Dis.
175:414-420[Medline].
|
| 10.
|
Currie, B. P., and A. Casadevall.
1994.
Estimation of the prevalence of cryptococcal infection among patients infected with the human immunodeficiency virus in New York City.
Clin. Infect. Dis.
19:1029-1033[Medline].
|
| 11.
|
Davies, S. F.,
D. P. Clifford,
J. R. Hoidal, and J. E. Repine.
1982.
Opsonic requirements for the uptake of Cryptococcus neoformans by human polymorphonuclear leukocytes and monocytes.
J. Infect. Dis.
145:870-874[Medline].
|
| 12.
|
DeShaw, M., and L.-A. Pirofski.
1995.
Antibodies to the Cryptococcus neoformans capsular glucuronoxylomannan are ubiquitous in serum from HIV+ and HIV individuals.
Clin. Exp. Immunol.
99:425-432[Medline].
|
| 13.
|
Diamond, R. D.,
R. K. Root, and J. E. Bennett.
1972.
Factors influencing killing of Cryptococcus neoformans by human leukocytes in vitro.
J. Infect. Dis.
125:367-376[Medline].
|
| 14.
|
Diamond, R. D., and J. E. Bennett.
1973.
Growth of Cryptococcus neoformans within human macrophages in vitro.
Infect. Immun.
7:231-236[Abstract/Free Full Text].
|
| 15.
|
Doty, S. B.,
C. E. Smith,
A. R. Hand, and C. Oliver.
1977.
Inorganic trimetaphosphatase as a histochemical marker for lysosomes in light and electron microscopy.
J. Histochem. Cytochem.
25:1381-1384[Abstract].
|
| 16.
|
Eissenberg, L. G.,
W. E. Goldman, and P. H. Schlesinger.
1993.
Histoplasma capsulatum modulates the acidification of phagolysosomes.
J. Exp. Med.
177:1605-1611[Abstract/Free Full Text].
|
| 17.
|
Ellis, D. H., and T. J. Pfeiffer.
1990.
Ecology, life cycle, and infectious propagule of Cryptococcus neoformans.
Lancet
336:923-925[CrossRef][Medline].
|
| 18.
|
Feldmesser, M., and A. Casadevall.
1997.
Effect of serum IgG1 to Cryptococcus neoformans glucuronoxylomannan on murine pulmonary infection.
J. Immunol.
158:790-799[Abstract].
|
| 19.
|
Feldmesser, M.,
A. Casadevall,
Y. Kress,
G. Spira, and A. Orlofsky.
1997.
Eosinophil-Cryptococcus neoformans interactions in vivo and in vitro.
Infect. Immun.
65:1899-1907[Abstract].
|
| 20.
|
Feldmesser, M.,
Y. Kress, and A. Casadevall.
1998.
Effect of antibody to capsular polysaccharide on eosinophilic pneumonia in murine infection with Cryptococcus neoformans.
J. Infect. Dis.
177:1639-1646[Medline].
|
| 21.
|
Franzot, S. P.,
J. Mukherjee,
R. Cherniak,
L.-C. Chen,
J. S. Hamdan, and A. Casadevall.
1998.
Microevolution of a standard strain of Cryptococcus neoformans resulting in differences in virulence and other phenotypes.
Infect. Immun.
66:89-97[Abstract/Free Full Text].
|
| 22.
|
Franzot, S. P.,
I. F. Salkin, and A. Casadevall.
1999.
Cryptococcus neoformans var. grubii: separate varietal status for Cryptococcus neoformans serotype A isolates.
J. Clin. Microbiol.
37:838-840[Abstract/Free Full Text].
|
| 23.
|
Fromtling, R. A.,
H. J. Shadomy, and E. S. Jacobson.
1982.
Decreased virulence in stable, acapsular mutants of Cryptococcus neoformans.
Mycopathologia
79:23-29[CrossRef][Medline].
|
| 24.
|
Gaillard, J.-L.,
P. Berche,
J. Mounier,
S. Richard, and P. Sansonetti.
1987.
In vitro model of penetration and intracellular growth of Listeria monocytogenes in the human enterocyte-like cell line Caco-2.
Infect. Immun.
55:2822-2829[Abstract/Free Full Text].
|
| 25.
|
Garcia-Hermoso, D.,
G. Janbon, and F. Dromer.
1999.
Epidemiological evidence for dormant Cryptococcus neoformans infection.
J. Clin. Microbiol.
37:3204-3209[Abstract/Free Full Text].
|
| 26.
|
Granger, D. L.,
J. R. Perfect, and D. T. Durack.
1986.
Macrophage-mediated fungistasis in vitro: requirements for intracellular and extracellular cytotoxicity.
J. Immunol.
136:672-680[Abstract].
|
| 27.
|
Granier, F.,
J. Kanitakis,
C. Hermier,
Y. Y. Zhu, and J. Thivolet.
1987.
Localized cutaneous cryptococcosis successfully treated with ketoconazole.
J. Am. Acad. Dermatol.
16:243-249[Medline].
|
| 28.
|
Graybill, J. R., and R. H. Alford.
1974.
Cell-mediated immunity in cryptococcosis.
Cell. Immunol.
14:12-21[CrossRef][Medline].
|
| 29.
|
Heinzen, R. A.,
M. A. Scidmore,
D. D. Rockey, and T. Hackstadt.
1996.
Differential interaction with endocytic and exocytic pathways distinguish parasitophorous vacuoles of Coxiella burnetii and Chlamydia trachomatis.
Infect. Immun.
64:796-809[Abstract].
|
| 30.
|
Hino, H.,
K. Takizawa, and G. Asboe-Hansen.
1982.
Ultrastructure of Cryptococcus neoformans.
Acta Dermatovenerol. Ingosl.
62:113-117.
|
| 31.
|
Huffnagle, G. B.,
M. B. Boyd,
N. E. Street, and M. F. Lipscomb.
1998.
IL-5 is required for eosinophil recruitment, crystal deposition, and mononuclear cell recruitment during a pulmonary Cryptococcus neoformans infection in genetically susceptible mice (C57BL/6).
J. Immunol.
160:2393-2400[Abstract/Free Full Text].
|
| 32.
|
Huffnagle, G. B.,
G.-H. Chen,
J. L. Curtis,
R. A. McDonald,
R. M. Strieter, and G. B. Toews.
1995.
Down-regulation of the afferent phase of T cell-mediated pulmonary inflammation and immunity by a high melanin-producing strain of Cryptococcus neoformans.
J. Immunol.
155:3507-3516[Abstract].
|
| 33.
|
Kalina, M.,
J. J. Bubis,
Y. Kletter,
A. Shahar, and M. Aronson.
1970.
Ultrastructural localization of acid phosphatase in the yeast Cryptococcus neoformans.
Experientia
26:287-288[CrossRef][Medline].
|
| 34.
|
Kalina, M.,
Y. Kletter,
A. Shahar, and M. Aronson.
1971.
Acid phosphatase release from intact phagocytic cells surrounding a lare-sized parasite (35275).
Proc. Soc. Exp. Biol. Med.
136:407-410[Medline].
|
| 35.
|
Kozel, T. R.,
M. A. Wilson, and J. W. Murphy.
1991.
Early events in initiation of alternative complement pathway activation by the capsule of Cryptococcus neoformans.
Infect. Immun.
59:3101-3110[Abstract/Free Full Text].
|
| 36.
|
Lee, S. C.,
Y. Kress,
M.-L. Zhao,
D. W. Dickson, and A. Casadevall.
1995.
Cryptococcus neoformans survive and replicate in human microglia.
Lab. Investig.
73:871-879[Medline].
|
| 37.
|
Levitz, S. M., and D. J. DiBenedetto.
1989.
Paradoxical role of capsule in murine bronchoalveolar macrophage-mediated killing of Cryptococcus neoformans.
J. Immunol.
142:659-665[Abstract].
|
| 38.
|
Levitz, S. M., and T. P. Farrell.
1990.
Growth inhibition of Cryptococcus neoformans by cultured human monocytes: role of the capsule, opsonins, the culture surface, and cytokines.
Infect. Immun.
58:1201-1209[Abstract/Free Full Text].
|
| 39.
|
Levitz, S. M.,
T. S. Harrison,
A. Tabuni, and X. Liu.
1997.
Chloroquine induces human mononuclear phagocytes to inhibit and kill Cryptococcus neoformans by a mechanism independent of iron deprivation.
J. Clin. Investig.
100:1640-1646[Medline].
|
| 40.
|
Levitz, S. M.,
S.-H. Nong,
K. F. Seetoo,
T. S. Harrison,
R. A. Speizer, and E. R. Simons.
1999.
Cryptococcus neoformans resides in an acidic phagolysosome of human macrophages.
Infect. Immun.
67:885-890[Abstract/Free Full Text].
|
| 41.
|
Littman, M. L.
1959.
Cryptococcosis (torulosis).
Am. J. Med.
27:976-988[CrossRef][Medline].
|
| 42.
|
Lovchik, J. A., and M. F. Lipscomb.
1993.
Role for C5 and neutrophils in the pulmonary intravascular clearance of circulating Cryptococcus neoformans.
Am. J. Respir. Cell Mol. Biol.
9:617-627.
|
| 43.
|
Mahvi, T. A.,
S. S. Spicer, and N. J. Wright.
1974.
Cytochemistry of acid mucosubstance and acid phosphatase in Cryptococcus neoformans.
Can. J. Microbiol.
20:833-838[Medline].
|
| 44.
|
Miller, G. P. G., and S. Kohl.
1983.
Antibody-dependent leukocyte killing of Cryptococcus neoformans.
J. Immunol.
131:1455-1459[Abstract].
|
| 45.
|
Mitchell, T. G., and J. R. Perfect.
1995.
Cryptococcosis in the era of AIDS 100 years after the discovery of Cryptococcus neoformans.
Clin. Microbiol. Rev.
8:515-548[Abstract].
|
| 46.
|
Mukherjee, S.,
S. Lee,
J. Mukherjee,
M. D. Scharff, and A. Casadevall.
1994.
Monoclonal antibodies to Cryptococcus neoformans capsular polysaccharide modify the course of intravenous infection in mice.
Infect. Immun.
62:1079-1088[Abstract/Free Full Text].
|
| 47.
|
Murphy, J. W.
1992.
Cryptococcal immunity and immunostimulation.
Adv. Exp. Med. Biol.
319:225-230[Medline].
|
| 48.
|
Noble, R. C., and L. F. Fajardo.
1971.
Primary cutaneous cryptococcosis: review and morphologic study.
Am. J. Clin. Pathol.
57:13-22.
|
| 49.
|
Nosanchuk, J. D.,
P. Valadon,
M. Feldmesser, and A. Casadevall.
1999.
Melanization of Cryptococcus neoformans in murine infection.
Mol. Cell. Biol.
19:745-750[Abstract/Free Full Text].
|
| 50.
|
Novikoff, P. M., and A. Yam.
1978.
Sites of lipoprotein particles in normal rat hepatocytes.
J. Cell Biol.
76:1-11[Abstract/Free Full Text].
|
| 51.
|
Papadimitriou, J. M.,
T. A. Robertson,
Y. Kletter,
M. Aronson, and M. N.-I. Walters.
1978.
An ultrastructural examination of the interaction between macrophages and Cryptococcus neoformans.
J. Pathol.
124:103-109[CrossRef][Medline].
|
| 52.
|
Retini, C.,
A. Vecchiarelli,
C. Monari,
C. Tascini,
F. Bistoni, and T. R. Kozel.
1996.
Capsular polysaccharide of Cryptococcus neoformans induces proinflammatory cytokine release by human neutrophils.
Infect. Immun.
64:2897-2903[Abstract].
|
| 53.
|
Richardson, M. D.,
L. J. White,
T. C. McKay, and G. S. Shankland.
1993.
Differential binding of acapsulate and encapsulated strains of Cryptococcus neoformans to human neutrophils.
J. Med. Vet. Mycol.
31:189-199[Medline].
|
| 54.
|
Sakaguchi, N.
1993.
Ultrastructural study of hepatic granulomas induced by Cryptococcus neoformans by quick-freezing and deep-etching method.
Virchows Arch.
64:57-66.
|
| 55.
|
Schelenz, S.,
R. Malhotra,
R. B. Sim,
U. Holmskov, and G. J. Bancroft.
1995.
Binding of host collectins to the pathogenic yeast Cryptococcus neoformans: human surfactant protein D acts as an agglutinin for acapsular yeast cells.
Infect. Immun.
63:3360-3366[Abstract].
|
| 56.
|
Schneerson-Porat, S.,
A. Shahar, and M. Aronson.
1965.
Formation of histiocyte rings in response to Cryptococcus neoformans infection.
J. Reticuloendothelial Soc.
2:249-255[Medline].
|
| 57.
|
Schwartz, D. A.
1988.
Characterization of the biological activity of Cryptococcus infections in surgical pathology. The budding index and carminophilic index.
Ann. Clin. Lab. Sci.
18:388-397[Abstract].
|
| 58.
|
Sheppe, W. M.
1924.
Torula infection in man.
Am. J. Med. Sci.
167:91-108.
|
| 59.
|
Tacker, J. R.,
F. Farhi, and G. S. Bulmer.
1972.
Intracellular fate of Cryptococcus neoformans.
Infect. Immun.
6:162-167[Abstract/Free Full Text].
|
| 60.
|
Wang, Y., and A. Casadevall.
1994.
Susceptibility of melanized an |